A New Medication Is Developed That Targets and Binds to the Lipid

question 70

Multiple Choice

A new medication is developed that targets and binds to the lipid A portion of LPS in Gram-negative bacterial cells. This drug shows a high degree of binding and activity against purified lipid A in an experiment carried out in test tubes. Based on this information,

• A) we should fast-track this drug and get it out to physicians immediately to help prevent Gram-negative toxic/septic shock in humans.
• B) we should do some animal testing with intact Gram-negative cells and the medication before we jump to any conclusions.
• C) we should next proceed by repeating the experiment in test tubes using intact Gram-negative cells to see if the drug binds with the same strength.
• D) we should abandon the drug entirely. Binding to lipid A won't kill the bacteria, so the drug is useless to develop further. 
• E) we should assume that the medication will be effective against all bacteria, including Mycoplasmas, and that it is ready for use in humans.

Understand the importance of customer perspective in closing sales.

Demonstrate knowledge of the twelve keys to successful closing.

Apply knowledge of closing techniques to real-world selling situations.

Understand various closing techniques and their appropriate contexts.

---

Definitions:

Horizontal Integration

A strategy where a firm grows by acquiring or merging with its competitors in the same industry to achieve economies of scale or scope.

Early Supply Involvement

The practice of involving suppliers at the early stages of a product development process to leverage their expertise and insights for better outcomes.

Competitive Advantage

The unique attributes or circumstances that allow a company to produce goods or services better or more cheaply than its competitors.

Supply Chain

The network of all entities involved in producing and delivering a final product to the consumer, including manufacturers, suppliers, and distributors.